Home/Filings/4/0002070664-26-000002
4//SEC Filing

Ball Robert Joseph 4

Accession 0002070664-26-000002

CIK 0001699350other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:35 PM ET

Size

5.4 KB

Accession

0002070664-26-000002

Research Summary

AI-generated summary of this filing

Updated

SHOULDER INNOVATIONS (SI) CEO Robert Ball Receives 265,351-Share Award

What Happened
Robert Joseph Ball, CEO & Executive Chairman and a director of SHOULDER INNOVATIONS, INC. (SI), was granted 265,351 derivative securities on January 30, 2026. The filing reports an acquisition price of $0.00 and a total reported value of $0 (this is a derivative grant, not an open-market cash purchase or sale). This transaction is an award (compensation grant) rather than a sale; it represents an issuance of equity-linked securities to the insider.

Key Details

  • Transaction date: 2026-01-30; filing date: 2026-02-03 (filed within the typical 2-business-day window).
  • Instrument: Derivative grant reported as "A" (award/acquisition). Reported acquisition price: $0.00. Quantity: 265,351 underlying shares.
  • Shares owned after transaction: Not specified in the provided data.
  • Footnote: The grant is a stock option that vests as to one-fourth of the underlying shares on March 1 each year, beginning March 1, 2027 (annual vesting schedule noted).
  • No indication in the filing that any shares were immediately sold or that this was a cashless exercise.

Context: This was an equity compensation award (a derivative stock-option grant) to an executive. Such grants are commonly used for retention and incentive and do not reflect an open-market purchase or sale. Because the award vests over time, the recipient does not immediately receive all underlying shares.

Insider Transaction Report

Form 4
Period: 2026-01-30
Ball Robert Joseph
DirectorCEO & Executive Chairman
Transactions
  • Award

    Stock Option

    [F1]
    2026-01-30+265,351265,351 total
    Exercise: $14.16Exp: 2033-01-30Common Stock (265,351 underlying)
Footnotes (1)
  • [F1]The stock option vests as to one-fourth of the underlying shares on March 1st each year, beginning on March 1, 2027.
Signature
/s/ Jeffrey Points, as Attorney-in-Fact|2026-02-03

Issuer

SHOULDER INNOVATIONS, INC.

CIK 0001699350

Entity typeother

Related Parties

1
  • filerCIK 0002070664

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:35 PM ET
Size
5.4 KB